Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

Returns vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

In a Q&A, the chairman of Dr Reddy’s Laboratories dwells, among other things, on the draft R&D policy and the first-ever Global Innovation Summit of the pharma sector held last November

Viral vaccines, vector platforms may become new growth areas: DRL chief

Hyderabad-based Dr Reddy’s Laboratories Ltd plans to launch its generic version of the Merck drug, called molnupiravir, from early next week

Centre says Covid antiviral drug Molnupiravir has ‘major safety concerns’

The total course of 40 capsules over 5 days would cost Rs 1,400 with 10 capsules per strip.

Dr Reddy’s Laboratories to launch Molflu at Rs 35 per capsule

Stocks in Focus on Jan 5: Airtel, GAIL, Dr Reddy’s Labs & More

Molnupiravir is an oral antiviral that inhibits the replication of multiple RNA viruses including SARS-CoV-2.

Dr Reddy’s Laboratories to Introduce Molnupiravir to Treat Covid-19 Shortly

​​The drug firm said it is able to manufacture the active pharmaceutical ingredient (API) as well as the formulation for Molnupiravir, and has made adequate capacity preparations to ensure that it is able to help patients in India as well as in patient populations in need around the world.

Dr Reddy’s Laboratories to introduce Molnupiravir to treat COVID-19 shortly

The Hyderabad-based firm said it will introduce the drug under the brand name Molflu in India

Dr Reddy’s Laboratories to introduce Molnupiravir to treat Covid-19 shortly

Indian giants Sun Pharmaceutical Industries, Optimus Pharma, and Dr Reddy’s Laboratories are exploring the possibility of manufacturing the pill, reports suggest.

Covid-19: How will Pfizer’s oral antiviral treatment drug Paxlovid come to India?

Nifty should be held long with the stoploss of 16,650.

Here’s why HDFC Securities is bullish on HCL Tech, Dr Reddy’s Labs

Dr Reddy’s Laboratories has sought permission from India’s drug regulator to conduct a phase-3 clinical trial to evaluate the efficacy and safety of Sputnik Light vaccine as a booster dose against covid-19 in India

India stock markets seen volatile; Paytm, Dr Reddy’s in focus

Stocks In the News: Check out the companies making the biggest headlines before the opening bell.

Buzzing Stocks: Tata Motors, IndusInd Bank, Dr Reddy’s Labs And Other Stocks In News Today

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines.

Dr Reddy's Laboratories Ltd

Dr Reddy's Laboratories Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Viral vaccines, vector platforms may become new growth areas: DRL chief

Centre says Covid antiviral drug Molnupiravir has ‘major safety concerns’

Dr Reddy’s Laboratories to launch Molflu at Rs 35 per capsule

Stocks in Focus on Jan 5: Airtel, GAIL, Dr Reddy’s Labs & More

Dr Reddy’s Laboratories to Introduce Molnupiravir to Treat Covid-19 Shortly

Dr Reddy’s Laboratories to introduce Molnupiravir to treat COVID-19 shortly

Dr Reddy’s Laboratories to introduce Molnupiravir to treat Covid-19 shortly

Covid-19: How will Pfizer’s oral antiviral treatment drug Paxlovid come to India?

Dr Reddy's Laboratories Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Viral vaccines, vector platforms may become new growth areas: DRL chief

Centre says Covid antiviral drug Molnupiravir has ‘major safety concerns’

Dr Reddy’s Laboratories to launch Molflu at Rs 35 per capsule

Stocks in Focus on Jan 5: Airtel, GAIL, Dr Reddy’s Labs & More

Dr Reddy’s Laboratories to Introduce Molnupiravir to Treat Covid-19 Shortly

Dr Reddy’s Laboratories to introduce Molnupiravir to treat COVID-19 shortly

Dr Reddy’s Laboratories to introduce Molnupiravir to treat Covid-19 shortly

Covid-19: How will Pfizer’s oral antiviral treatment drug Paxlovid come to India?

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock